查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1372862

生物晶片市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按技術、類型、按應用、最終用戶、地區和競爭細分

Biochip Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technology, By Type, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022年，全球生物晶片市場估值達到149.6億美元，預計在預測期內將呈現令人印象深刻的成長，到2028年將維持14.09%的年複合成長率（CAGR）。生物晶片是微型醫療設備的精心代表設計用於同時執行多個生化反應，顯著減少分析所需的時間。這些裝置包括精心排列在固體基質上的微測試位點或微陣列。生物晶片有多種形式，包括 DNA、蛋白質、酵素和晶片實驗室變體。這些緊湊而強大的設備在設計時考慮到方便用戶使用性，並提供精確的關鍵見解。它們在儲存個人醫療和財務資訊方面特別有用，並且可以用於個人追蹤。當植入人體後，生物晶片在監測、分析和調節患者健康和生物過程方面發揮關鍵作用。此外，它們還對危險識別、確保環境安全和加強決策過程做出了重大貢獻。因此，生物晶片在全球範圍內的基因診斷、腫瘤學、發炎診斷和分子分析等領域得到了廣泛的應用。

主要市場促進因素

生物晶片在個人化醫療的應用越來越廣泛

市場概況
預測期 2024-2028
2022 年市場規模 149.6億美元
2028 年市場規模 330.4億美元
2023-2028 年年複合成長率 14.09%
成長最快的細分市場 藥物發現與開發
最大的市場 北美洲

生物晶片在即時診斷和分子診斷中發揮著至關重要的作用，推動了對其在個人化醫療中應用的高需求。事實證明，這些晶片在區分正常細胞和癌細胞方面具有無價的價值，可以快速分析整個蛋白質組，以用於基於蛋白質的治療。此外，它們可以作為可靠的工具，以有限的樣本量檢測多種生物標記物，為疾病診斷和治療提供巨大潛力。因此，個人化醫療對生物晶片的需求持續飆升。

技術進步不斷增強

隨著技術的進步，生物晶片在蛋白質體學中的使用顯著增加。隨著奈米技術的進步，生物晶片由於其增強的功能、減小的尺寸和更廣泛的應用而變得更加有價值。它們現在廣泛應用於診斷、研究、藥物開發和毒理學研究。這些多功能晶片在基因分型、勝肽、客製化醫療和其他各個領域都有應用，這促進了老牌製造商和年輕企業家的新技術的出現。隨著對生物晶片的需求持續成長，市場見證了創新產品和研發資金的激增。

即時檢測的需求不斷增加

對即時檢測 (POC) 測試的需求不斷成長，將對診斷和醫療保健領域對生物晶片的需求產生重大積極影響。 POC 測試是指在患者附近進行的診斷測試，通常在床邊或門診環境中進行，無需集中實驗室設施即可快速提供結果。生物晶片（也稱為微陣列）因其多功能性、高效性以及對小型化、高通量診斷應用的適用性而成為 POC 測試的關鍵推動者。

POC 測試可以增強醫療保健服務的可近性，特別是在服務不足或無法進入集中實驗室的偏遠地區。基於生物晶片的 POC 測試是攜帶式的，可以在資源有限的環境中使用。生物晶片可以分析個別患者的生物標記物，從而可以根據患者獨特的基因組成製定個人化的治療計劃，這是現代醫學的基石。

由於對更快、更方便和個性化診斷的需求的推動，對 POC 測試的需求不斷成長，預計將推動對生物晶片的需求。隨著生物晶片技術不斷發展並適應新出現的醫療保健挑戰，它有望在改變醫療診斷格局和改善全球患者護理方面發揮關鍵作用。

蛋白質體學和基因體學在癌症研究的應用不斷增加

蛋白質體學和基因組學在癌症研究中的日益增多的應用將顯著增加對生物晶片的需求，徹底改變癌症的診斷、表徵和治療方式。生物晶片，也稱為微陣列，由於能夠在一次實驗中同時分析數千個基因或蛋白質，因此成為這一領域的強大工具。識別早期癌症檢測、預後和治療反應的可靠生物標記至關重要。生物晶片使研究人員能夠快速有效地篩選大量潛在的生物標記物，加速發現具有診斷和治療意義的新型標記。

生物晶片在藥物發現和開發中發揮著至關重要的作用。它們有助於篩選針對癌症相關蛋白質或基因的化合物或治療劑，幫助識別潛在的候選藥物並推進標靶治療的開發。生物晶片使研究人員能夠同時分析多個基因或蛋白質，從而減少綜合癌症研究所需的時間和資源，從而提高研究效率。

隨著癌症研究範圍的擴大以及人們對蛋白質組學和基因組學在理解癌症分子複雜性方面的價值的日益認知，對生物晶片的需求預計將隨之成長。隨著精準醫療在腫瘤學領域變得越來越普遍，生物晶片將繼續在提高我們對癌症生物學的了解以及透過更有針對性和有效的治療來改善患者治療效果方面發揮關鍵作用。

主要市場挑戰

生物駭客攻擊和隱私問題的可能性很高

生物晶片是一種插入手中的微型設備，透過加快任務速度徹底改變了日常生活。這些尖端晶片具有多種優勢，例如無縫訪問家庭、健身房和辦公室，以及方便地儲存緊急聯絡人、社交媒體資料和電子機票。值得注意的是，瑞典選擇將這些微晶片植入手中的人數激增。然而，科學家對與生物晶片相關的潛在資料外洩和駭客攻擊漏洞表示擔憂。這些晶片能夠追蹤位置、監控消費習慣，甚至記錄駕駛行為，因此容易受到未經授權的存取。此外，體內晶片的存在會帶來感染風險，並引發對個人自由的質疑。針對這些擔憂，美國最近實施了禁止強制使用生物晶片的法規。預計由於生物駭客風險和隱私問題，市場收入成長可能面臨限制。加強安全措施和解決隱私問題對於這項創新產業的永續成長至關重要。

生物晶片成本高且缺乏認知

生物晶片技術的開發是一個成本高度密集的過程。它需要大量的研究和開發工作以及熟練的開發人員，這最終導致最終產品的成本高昂。生物晶片系統本身由在玻璃表面上精心排列的微型探針組成。這些微型樣品需要精確的處理和掃描，這需要使用自動化機器人儀器。實施該技術所需的方法和工具的複雜性和特殊性也導致了其高成本。

由於這些因素，生物晶片的商業用途受到阻礙，主要是由於其生產和實施的高價格。此外，人們對生物晶片缺乏認知，特別是在發展中國家，這進一步限制了預測期內潛在的市場收入成長。

主要市場趨勢

擴大採用生物晶片來檢測過敏

許多人都曾遇到各種類型的過敏，例如食物、花粉等，導致一系列症狀，包括發燒、皮膚反應、嘔吐、氣喘和腹瀉。為了解決這些問題，過敏測試領域出現了一種引人注目的新技術，即過敏測試生物晶片。該技術目前正在經歷顯著成長，並涉及使用包含不同過敏原成分的微陣列。透過利用這些生物晶片，醫療保健專業人員能夠在一次測量中研究患者特定的致敏模式，從而提高過敏診斷的準確性和效率。

此外，生物晶片在過敏研究中的潛力促使公司投資於新技術的開發。例如，2021年4月，東麗工業宣布成功開發過敏測試生物晶片，能夠從微量血液中檢測多種過敏原特異性免疫球蛋白E（IgE）抗體。這項突破性創新為提高過敏測試的精確度和有效性帶來了巨大的希望。

擴大採用生物晶片來檢測和測試過敏原，預計將成為整個預測期內過敏測試市場收入成長的主要推動力。隨著越來越多的醫療保健提供者和研究人員認知到這項先進技術所提供的優勢，其廣泛實施將徹底改變過敏診斷領域，從而改善患者護理和治療結果。

生物晶片在不同領域的使用不斷增加

生物晶片技術廣泛應用於微生物學、DNA分析、臨床病理學、藥理學、直腸學和生物化學等多個領域。正在進行的研究工作將推動生物晶片技術的採用，特別是在醫療保健產業，從而在未來幾年進一步擴大其在主流市場的使用。生物晶片技術也應用於序列工程，這將促進全球生物晶片市場的成長，並提高生物晶片解決方案的性能和可擴展性。生物晶片製造商正專注於創新其微型實驗室的獨特方面，以便能夠有效地與生物體一起發揮作用。

生物晶片已成為 DNA 定序技術革命的關鍵組成部分。此外，它們可能為先進的基因定序解決方案鋪平道路。基因定序技術與生物晶片的整合將解決各種生物組織的問題，從而實現稀有細胞、單細胞和紅色分子分析。儘管如此，生物晶片技術的持續發展及其不斷擴大的通量能力預計將擴大其應用範圍，從以人群為中心的臨床研究到稀有細菌的檢測。製造商正在對用於單細胞分析的生物晶片進行大量投資，這將有助於改進生物晶片及其多功能功能，從而成倍提高性能。

細分市場洞察

類型洞察

全球生物晶片市場分為多種類型，包括DNA晶片、晶片實驗室、蛋白質晶片等。其中，晶片實驗室預計在預測期內將呈現快速的收入成長率。這可以歸因於蛋白質體學、細胞生物學、分子生物學、化學等多種應用對生物晶片的高需求。片上實驗室設備具有多種優勢，包括成本效率、高並行化、低體積試劑、高可擴展性和高靈敏度。預計這些因素將推動晶片實驗室領域的成長。此外，晶片實驗室技術在生物醫學診斷和分析化學中發揮著至關重要的作用。此外，在晶片實驗室中進行的雙分子操作可以實現超快速的病毒和細菌檢測，這使其對於分子生物學非常有價值。

應用洞察

根據應用，全球生物晶片市場分為藥物發現與開發、疾病診斷、基因體學、蛋白質體學、體外診斷等。由於體外診斷（IVD）對生物晶片的需求不斷成長，預計體外診斷領域將在預測期內佔據重要的收入佔有率。這包括 DNA 分析、晶片實驗室技術、蛋白質微陣列和其他陣列應用等應用。生物晶片還可以用於其他 IVD 解決方案，例如毒物基因組學和高通量篩選。例如，2022 年 1 月，馬德里理工大學 (UPM) 和馬德里卡洛斯三世大學 (UC3M) 的研究人員開發了一種生物晶片，可以簡化實驗室環境中體外皮膚和其他多層組織的製造過程。

由於基因組學研究中擴大採用生物晶片，預計基因組學領域的收入將在預測期內快速成長。基因組學是一種用於研究生物體基因組的結構和功能的技術。 DNA 微陣列和生物晶片技術的使用產生了大量資料，能夠對人類基因組進行詳細分析，並推動基因組學研究對這些晶片的需求。

區域洞察

北美在整個預測期內佔據市場主導地位，這主要是由於政府透過稅收激勵措施共同努力促進研發。由於生物技術企業、學術和研究組織的高度集中，以及預計未來生物晶片應用領域的技術進步，該地區預計將保持其工業地位。另一方面，在中國和印度的推動下，亞太地區市場可望實現巨大成長。擴大新技術的使用範圍、龐大的患者基礎、醫療保健系統的進步以及生物晶片技術的日益利用是影響該地區擴張的關鍵因素。成熟企業正在將生物晶片生產委託給新興經濟體，旨在降低整體成本。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球生物晶片市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術分類（微陣列與微流體）
    • 按類型（DNA 晶片、晶片實驗室、蛋白質晶片、其他）
    • 按應用（藥物發現與開發、疾病診斷、基因體學、蛋白質體學、體外診斷等）
    • 按最終用戶（醫院和診斷中心、學術和研究機構、生物技術和製藥公司、其他）
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖

第 6 章：北美生物晶片市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲生物晶片市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區生物晶片市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲生物晶片市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲生物晶片市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非生物晶片
    • 沙烏地阿拉伯生物晶片
    • 阿拉伯聯合大公國生物晶片

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球生物晶片市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 服務內容
  • 最近的發展
  • 主要人員
  • SWOT分析
    • Abbott Laboratories Inc.
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • Fluidigm Corporation
    • Thermo Fisher Scientific Inc.
    • PerkinElmer Inc.
    • Illumina Inc.
    • Phalanx Biotech Group Inc.
    • BioMerieux SA
    • Qiagen NV

第 16 章：策略建議

第 17 章：關於我們與免責聲明

簡介目錄
Product Code: 1259

In 2022, the Global Biochip Market reached a valuation of USD 14.96 Billion, and it is poised to demonstrate impressive growth during the forecast period, maintaining an impressive Compound Annual Growth Rate (CAGR) of 14.09% through 2028. Biochips represent miniature medical devices meticulously engineered to perform multiple biochemical reactions simultaneously, significantly reducing the required time for analysis. These devices comprise micro-test sites or microarrays meticulously arranged on a solid substrate. Biochips are available in various forms, encompassing DNA, protein, enzyme, and lab-on-a-chip variants. These compact and potent devices are designed with user-friendliness in mind and offer precise critical insights. They find particular utility in storing personal medical and financial information and can be harnessed for individual tracking. When implanted within the human body, biochips play a pivotal role in monitoring, analyzing, and regulating patient health and biological processes. Furthermore, they contribute significantly to hazard identification, ensuring environmental safety and enhancing decision-making processes. As a result, biochips find wide-ranging applications in fields such as gene diagnostics, oncology, inflammatory diagnosis, and molecular analysis on a global scale.

Key Market Drivers

Growing Use of Biochips in Personalized Medicine

Market Overview
Forecast Period2024-2028
Market Size 2022USD 14.96 Billion
Market Size 2028USD 33.04 Billion
CAGR 2023-202814.09%
Fastest Growing SegmentDrug Discovery & Development
Largest MarketNorth America

Biochips play a crucial role in point-of-care diagnosis and molecular diagnostics, driving high demand for their application in personalized medicine. These chips prove invaluable in distinguishing between normal and cancerous cells, enabling rapid analysis of the entire proteome for protein-based therapeutics. Moreover, they serve as reliable tools for detecting a wide range of biomarkers with limited sample quantities, offering immense potential in disease diagnosis and treatment. Consequently, the demand for biochips in personalized medicine continues to soar.

The use of Biochips in molecular diagnostics and point-of-care diagnosis is expected to create a significant demand for these chips in advancing customized medicine. These innovative chips play a crucial role in accurately identifying and differentiating between healthy and malignant cells' proteins, providing valuable insights for protein-based treatments. One of the key advantages of Biochips is their ability to facilitate a comprehensive study of the complete proteome in a quick and efficient manner. Their high demand in personalized medicine stems from their reliability in identifying a wide range of indicators using a limited number of samples, while also offering the potential for effective diagnosis and treatment of various conditions. With their unique capabilities, Biochips are poised to revolutionize the field of personalized medicine and contribute to the advancement of tailored healthcare solutions.

Increased Technological Advancement

The use of Biochips in proteomics has significantly increased alongside technological advancements. With the progress in nanotechnology, Biochips have become even more valuable due to their enhanced functionality, reduced size, and wider range of applications. They are now extensively utilized in diagnostics, research, medication development, and toxicological studies. These versatile chips find applications in genotyping, peptides, customized medicine, and various other fields, which has fostered the emergence of new technologies by both established manufacturers and young entrepreneurs. As the demand for Biochips continues to grow, the market is witnessing a surge in innovative products and funding for research and development.

Increasing Demand for Point-of-care Testing

The increasing demand for point-of-care (POC) testing is poised to have a significant positive impact on the demand for biochips in the field of diagnostics and healthcare. POC testing refers to diagnostic tests that are conducted near the patient, often at the bedside or in outpatient settings, providing rapid results without the need for centralized laboratory facilities. Biochips, also known as microarrays, are a key enabler of POC testing due to their versatility, efficiency, and suitability for miniaturized, high-throughput diagnostic applications.

POC testing can enhance access to healthcare services, particularly in underserved or remote areas with limited access to centralized laboratories. Biochip-based POC tests are portable and can be used in resource-limited settings. Biochips enable the profiling of individual patient biomarkers, allowing for personalized treatment plans tailored to a patient's unique genetic makeup, which is a cornerstone of modern medicine.

The increasing demand for POC testing, driven by the need for faster, more convenient, and personalized diagnostics, is expected to boost the demand for biochips. As biochip technology continues to evolve and adapt to emerging healthcare challenges, it is poised to play a pivotal role in transforming the landscape of healthcare diagnostics and improving patient care globally.

Increasing Application of Proteomics and Genomics in Cancer Research

The increasing application of proteomics and genomics in cancer research is poised to significantly boost the demand for biochips, revolutionizing the way cancer is diagnosed, characterized, and treated. Biochips, also known as microarrays, serve as powerful tools in this endeavor due to their ability to simultaneously analyze thousands of genes or proteins in a single experiment. Identifying reliable biomarkers for early cancer detection, prognosis, and treatment response is essential. Biochips enable researchers to screen large numbers of potential biomarkers quickly and efficiently, accelerating the discovery of novel markers with diagnostic and therapeutic significance.

Biochips play a vital role in drug discovery and development. They facilitate the screening of compounds or therapeutic agents against cancer-related proteins or genes, helping identify potential drug candidates and advancing the development of targeted therapies. Biochips enhance research efficiency by enabling researchers to analyze multiple genes or proteins simultaneously, reducing the time and resources required for comprehensive cancer studies.

The demand for biochips is expected to grow in tandem with the expanding scope of cancer research and the increasing recognition of the value of proteomics and genomics in understanding the molecular intricacies of cancer. As precision medicine becomes more commonplace in oncology, biochips will continue to play a pivotal role in advancing our knowledge of cancer biology and improving patient outcomes through more targeted and effective treatments.

Key Market Challenges

High Chances of Biohacking and Privacy Concern

Biochips, tiny devices inserted into the hands, have revolutionized daily routines by expediting tasks. These cutting-edge chips offer a multitude of benefits, such as seamless access to homes, gyms, and offices, along with the convenience of storing emergency contacts, social media profiles, and e-tickets. Notably, Sweden has witnessed a surge in individuals opting to have these microchips implanted in their hands. However, scientists have raised concerns regarding potential data breaches and hacking vulnerabilities associated with biochips. These chips have the capability to track locations, monitor spending habits, and even record driving behaviors, making them susceptible to unauthorized access. Moreover, the presence of chips inside the body poses infection risks and raises questions about individual freedom. In response to these concerns, the United States has recently implemented regulations to prohibit the forced usage of biochips. It is anticipated that the market's revenue growth may face constraints due to the risks of biohacking and privacy concerns. The need for enhanced security measures and addressing privacy issues is crucial for the sustainable growth of this innovative industry.

High Cost and Lack of Awareness Regarding Biochips

The development of bio-chip technology is a highly cost-intensive process. It requires extensive research and development efforts, as well as skilled developers, which ultimately contributes to the high cost of the end-product. The biochip system itself consists of microscale probes that are carefully formatted on glass surfaces. These microscale samples require precise handling and scanning, which necessitates the use of automated robotic instruments. The complexity and specificity of the methodologies and tools required for implementing this technology also contribute to its high cost.

Due to these factors, the commercial use of biochips has been hindered, primarily due to the high price associated with their production and implementation. Furthermore, there is a lack of awareness regarding biochips, particularly in developing countries, which further limits the potential market revenue growth during the forecast period.

Key Market Trends

Increasing Adoption of Biochips For Detecting Allergies

Many individuals have encountered various types of allergies, such as food, pollen, and others, resulting in a range of symptoms including fever, skin reactions, vomiting, asthma, and diarrhea. To address these issues, the field of allergy testing has witnessed the emergence of a remarkable new technology known as allergy testing biochips. This technology is currently experiencing significant growth and involves the use of microarrays that contain different allergen components. By utilizing these biochips, healthcare professionals are able to investigate patient-specific sensitization patterns in a single measurement, thus enhancing the accuracy and efficiency of allergy diagnoses.

Furthermore, the potential of biochips in allergy research has prompted companies to invest in the development of new technologies. For example, in April 2021, Toray Industries made an announcement regarding the successful development of allergy testing biochips capable of detecting multiple allergen-specific immunoglobin E (IgE) antibodies from trace amounts of blood. This breakthrough innovation holds tremendous promise for improving the precision and effectiveness of allergy testing.

The increasing adoption of biochips for detecting and testing allergens is expected to be a major driver for revenue growth in the allergy testing market throughout the forecast period. As more healthcare providers and researchers recognize the advantages offered by this advanced technology, its widespread implementation will revolutionize the field of allergy diagnostics, leading to improved patient care and outcomes.

Growing Usage of Biochips in Diverse Areas

Biochip technologies are extensively utilized across a range of fields, including microbiology, DNA analysis, clinical pathology, pharmacology, proctology, and biochemistry, among others. Ongoing research endeavors will drive the adoption of biochip technologies, particularly in the healthcare industry, thus further expanding their usage in the mainstream market in the coming years. Biochip technology is also employed in sequence engineering, which is poised to boost the growth of the global biochip market and enhance the performance and scalability of biochip solutions. Manufacturers of biochips are focusing on innovating distinct aspects of their miniature laboratories that can effectively function with living organisms.

Biochips have emerged as a pivotal component in revolutionizing DNA sequencing technology. Moreover, they are likely to pave the way for advanced gene sequencing solutions. The integration of gene sequencing technology and biochips will address various biological tissues, enabling rare cell, single-cell, and red molecule analysis. Nevertheless, the continuous growth of biochip technology and its expanding throughput capacity are expected to broaden its applications, ranging from population-centric clinical studies to the detection of rare bacteria. Manufacturers are making substantial investments in biochips for single-cell analysis, which will contribute to the improvement of biochips and their versatile functions, consequently enhancing performance exponentially.

Segmental Insights

Type Insights

The global biochip market is categorized into various types, including DNA chip, lab-on-a-chip, protein chip, and others. Among these, lab-on-a-chip is projected to exhibit a rapid revenue growth rate during the forecast period. This can be attributed to the high demand for biochips in diverse applications such as proteomics, cell biology, molecular biology, chemistry, and others. Lab-on-chip devices offer multiple advantages, including cost efficiency, high parallelization, low volume reagents, high expandability, and high sensitivity. These factors are anticipated to drive the growth of the lab-on-chip segment. Moreover, lab-on-chip technology plays a crucial role in biomedical diagnostics and analytical chemistry. Additionally, the bimolecular operations performed in lab-on-chips enable ultra-fast virus and bacteria detection, making it highly valuable for molecular biology.

Application Insights

Based on application, the global biochip market is categorized into Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, In-vitro diagnostics, and Others. The In-vitro diagnostics segment is projected to hold a significant revenue share over the forecast period, driven by the increasing demand for biochips in In-Vitro Diagnostics (IVD). This includes applications such as DNA analysis, lab-on-chip technology, protein microarrays, and other array applications. Biochips also find utility in other IVD solutions like toxio-genomics and High Throughput Screening. For example, in January 2022, researchers from the Universidad Politecnica de Madrid (UPM) and the Universidad Carlos III de Madrid (UC3M) developed a biochip that simplifies the manufacturing process of in-vitro skin and other multilayer tissues in a laboratory setting.

The Genomics segment is expected to witness rapid revenue growth during the forecast period due to the increasing adoption of biochips in genomics research. Genomics is a technique used to study the structure and function of an organism's genome. The use of DNA microarrays and biochip technologies has generated vast amounts of data, enabling detailed analysis of the human genome and driving the demand for these chips in genomics research.

Regional Insights

North America dominates the market throughout the projection period, primarily due to the government's concerted efforts to boost R&D through tax incentives. This region is expected to maintain its industrial position, thanks to its high concentration of biotechnology businesses, academic and research organizations, and projected future technological advancements in Biochip applications. The Asia-Pacific regional market, on the other hand, is poised for tremendous growth, driven by China and India. Expanding access to new technologies, a sizable patient base, advancements in the healthcare system, and the increasing utilization of Biochip technology are key factors influencing the region's expansion. Mature businesses are delegating Biochip production to emerging economies, aiming to reduce overall costs.

Key Market Players

  • Abbott Laboratories Inc.
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Fluidigm Corporation
  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc.
  • Illumina Inc.
  • Phalanx Biotech Group Inc.
  • BioMerieux SA
  • Qiagen NV

Report Scope:

In this report, the Global Biochip Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biochip Market, By Technology:

  • Microarray
  • Microfluidics

Biochip Market, By Type:

  • DNA Chips
  • Lab-On-a-Chips
  • Protein Chips
  • Others

Biochip Market, By Application:

  • Drug Discovery & Development
  • Disease Diagnostics
  • Genomics
  • Proteomics
  • In-vitro diagnostics
  • Others

Biochip Market, By End User:

  • Hospitals & Diagnostics Centres
  • Academic & Research Institutes
  • Biotechnology & Pharmaceutical Companies
  • Others

Biochip Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Biochip Market.

Available Customizations:

  • Global Biochip market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biochip Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Microarray v/s Microfluidics)
    • 5.2.2. By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others)
    • 5.2.3. By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, In-vitro diagnostics and Others)
    • 5.2.4. By End User (Hospitals & Diagnostics Centers, Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Market Map

6. North America Biochip Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Type
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biochip Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Biochip Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Biochip Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Biochip Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Type
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Biochip Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. United Kingdom Biochip Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Italy Biochip Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. France Biochip Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Biochip Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia-Pacific Biochip Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Type
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Biochip Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Biochip Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Biochip Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Biochip Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Biochip Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. South America Biochip Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Type
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Biochip Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina Biochip Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Biochip Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. Middle East and Africa Biochip Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Type
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Biochip Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Biochip Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Biochip Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Products Launches

13. Global Biochip Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Abbott Laboratories Inc.
    • 15.5.2. Agilent Technologies Inc.
    • 15.5.3. Bio-Rad Laboratories Inc.
    • 15.5.4. Fluidigm Corporation
    • 15.5.5. Thermo Fisher Scientific Inc.
    • 15.5.6. PerkinElmer Inc.
    • 15.5.7. Illumina Inc.
    • 15.5.8. Phalanx Biotech Group Inc.
    • 15.5.9. BioMerieux SA
    • 15.5.10. Qiagen NV

16. Strategic Recommendations

17. About Us & Disclaimer